In CRC patients, several groups have shown that loss of PTEN correlates with local recurrence, advanced stage, lymph node metastasis and poorer CSS, suggesting a link between PTEN loss and an invasive CRC phenotype [36–38]. This evidence concerns the gene PTEN and metastatic malignant neoplasm in the lymph nodes.